If you continue to experience pain or discomfort, consult with a healthcare professional
Some users may combine BPC-157 with other tissue repair-promoting peptides such as TB-500
Inflammatory Bowel Disease (IBD) and Colitis In models of ulcerative colitis and Crohns-like inflammation, BPC-157 reduced symptoms such as: Intestinal bleeding Epithelial erosion Immune cell infiltration Weight loss and diarrhea BPC-157 therapy improved outcomes in acetic acid-induced colitis models, reducing oxidative stress and promoting mucosal regeneration. Tkalcevic, V
Clinical use in humans is based on extrapolation from preclinical data, clinical experience, and case reports
Use peptides strategically as part of a plan including sleep, stress management, and, if necessary, short bursts of anti-anxiety or anti-mood medications that may blunt drive